Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Individually tailored treatment of medication nonadherence.

Hommel KA, Herzer M, Ingerski LM, Hente E, Denson LA.

J Pediatr Gastroenterol Nutr. 2011 Oct;53(4):435-9. doi: 10.1097/MPG.0b013e3182203a91.

2.

Review article: medication non-adherence in ulcerative colitis--strategies to improve adherence with mesalazine and other maintenance therapies.

Hawthorne AB, Rubin G, Ghosh S.

Aliment Pharmacol Ther. 2008 Jun;27(12):1157-66. doi: 10.1111/j.1365-2036.2008.03698.x. Epub 2008 Mar 31. Review.

3.

Adherence to anti-TNF therapy in inflammatory bowel diseases: a systematic review.

Lopez A, Billioud V, Peyrin-Biroulet C, Peyrin-Biroulet L.

Inflamm Bowel Dis. 2013 Jun;19(7):1528-33. doi: 10.1097/MIB.0b013e31828132cb. Review.

PMID:
23518810
4.

Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine.

Su C, Lichtenstein GR.

Gastroenterol Clin North Am. 2004 Jun;33(2):209-34, viii. Review.

PMID:
15177535
5.

Medication nonadherence: an unrecognized cardiovascular risk factor.

Munger MA, Van Tassell BW, LaFleur J.

MedGenMed. 2007 Sep 19;9(3):58. Review.

6.

Practical strategies for enhancing adherence to treatment regimen in inflammatory bowel disease.

Greenley RN, Kunz JH, Walter J, Hommel KA.

Inflamm Bowel Dis. 2013 Jun;19(7):1534-45. doi: 10.1097/MIB.0b013e3182813482. Review.

7.

Interventions to improve adherence to antiretroviral therapy in children with HIV infection.

Bain-Brickley D, Butler LM, Kennedy GE, Rutherford GW.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD009513. doi: 10.1002/14651858.CD009513. Review.

PMID:
22161452
8.

[The problems of compliance and adherence, using the example of chronic inflammatory bowel disease].

Zimmerer T, Siegmund SV, Singer MV.

Dtsch Med Wochenschr. 2009 Jul;134(27):1417-24. doi: 10.1055/s-0029-1225298. Epub 2009 Jun 23. Review. German.

PMID:
19551607
9.

Assessing medication adherence in the elderly: which tools to use in clinical practice?

MacLaughlin EJ, Raehl CL, Treadway AK, Sterling TL, Zoller DP, Bond CA.

Drugs Aging. 2005;22(3):231-55. Review.

PMID:
15813656
11.

[Questions and answers on the role of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel disease].

Gisbert JP, Gomollón F, Maté J, Pajares JM.

Gastroenterol Hepatol. 2002 Jun-Jul;25(6):401-15. Review. Spanish. No abstract available.

PMID:
12069704
12.

Clinical impact and drivers of non-adherence to maintenance medication for inflammatory bowel disease.

Selinger CP, Robinson A, Leong RW.

Expert Opin Drug Saf. 2011 Nov;10(6):863-70. doi: 10.1517/14740338.2011.583915. Epub 2011 May 9. Review.

PMID:
21548837
13.

Nonadherence in patients with breast cancer receiving oral therapies.

Moore S.

Clin J Oncol Nurs. 2010 Feb;14(1):41-7. doi: 10.1188/10.CJON.41-47. Review.

PMID:
20118025
14.

The future of inflammatory bowel disease care.

Sandborn WJ.

Rev Gastroenterol Disord. 2009 Summer;9(3):E69-77. Review.

PMID:
19898267
15.

Review of medication adherence in children and adults with ADHD.

Adler LD, Nierenberg AA.

Postgrad Med. 2010 Jan;122(1):184-91. doi: 10.3810/pgm.2010.01.2112. Review.

PMID:
20107302
16.

Treatment regimen adherence in pediatric gastroenterology.

Hommel KA, Mackner LM, Denson LA, Crandall WV.

J Pediatr Gastroenterol Nutr. 2008 Nov;47(5):526-43. doi: 10.1097/MPG.0b013e318175dda1. Review.

17.

Medication nonadherence and psychiatry.

Chapman SC, Horne R.

Curr Opin Psychiatry. 2013 Sep;26(5):446-52. doi: 10.1097/YCO.0b013e3283642da4. Review.

Items per page

Supplemental Content

Write to the Help Desk